RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.79

Change

+0.20 (+2.12)%

Market Cap

N/A

Volume

700.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

+0.01 (+0.09%)

USD 1.12B
SOXS Direxion Daily Semiconductor B..

-0.14 (-0.67%)

USD 0.85B
PSQ ProShares Short QQQ

+0.03 (+0.08%)

USD 0.58B
SPXU ProShares UltraPro Short S&P50..

+0.14 (+0.56%)

USD 0.54B
SDOW ProShares UltraPro Short Dow30

+0.19 (+1.44%)

USD 0.31B
DOG ProShares Short Dow30

+0.12 (+0.45%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

+0.03 (+0.27%)

USD 0.16B
RWM ProShares Short Russell2000

+0.15 (+0.78%)

USD 0.15B
DUST Direxion Daily Gold Miners Ind..

+0.21 (+4.05%)

USD 0.12B
FNGD MicroSectors FANG+ Index -3X I..

-0.44 (-1.96%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.94% 69% C- 11% F
Dividend Return 3.50% 60% D- 61% D-
Total Return -14.44% 71% C- 11% F
Trailing 12 Months  
Capital Gain -26.67% 73% C 7% C-
Dividend Return 4.04% 68% D+ 53% F
Total Return -22.63% 71% C- 7% C-
Trailing 5 Years  
Capital Gain -78.62% 59% D- 4% F
Dividend Return 2.14% 53% F 6% D-
Total Return -76.49% 56% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.97% N/A N/A 45% F
Dividend Return 3.02% N/A N/A 39% F
Total Return 1.04% N/A N/A 24% F
Risk Return Profile  
Volatility (Standard Deviation) 249.65% N/A N/A 3% F
Risk Adjusted Return 1.21% N/A N/A 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike